Le Dräger PulmoVista® 500 SW 1.30 embodies a revolution in the field of ventilatory and respiratory monitoring, setting new standards for visibility into lung ventilation. Thanks to the cutting-edge technology of electrical impedance tomography (EIT), this device provides clinicians with an unprecedented view of the regional distribution of ventilation in the lungs. This non-invasive, real-time approach at the patient's bedside transforms how we understand and manage pulmonary function.
Protective lung ventilation requires precise settings such as positive end-expiratory pressure (PEP) and tidal volume. The PulmoVista® 500 simplifies this complexity by offering continuous and direct visualization of ventilation in different lung zones, facilitating personalized therapy. This approach allows clinicians to maintain the best possible air distribution in the lungs while monitoring the potential effects of various pulmonary conditions.
The device allows for a detailed assessment of ventilation distribution and changes in lung volume at the end of expiration. This provides the opportunity to observe the effects of therapeutic interventions and control outcomes over time. Clinicians can adjust ventilation parameters in real-time to optimize respiratory care.
The PulmoVista® 500 offers continuous and non-invasive monitoring of pulmonary function, directly at the patient's bedside. A flexible silicone belt, equipped with 16 integrated electrodes, adjusts around the patient's chest. This approach eliminates the need for invasive or stressful maneuvers, while avoiding exposure to ionizing radiation. Monitoring can extend up to 24 hours, providing an in-depth understanding of the patient's pulmonary dynamics.
In addition to images, the device generates real-time global and regional impedance curves and parameters, providing crucial information to guide clinical decision-making. Trends in ventilation distribution and changes in lung volume at the end of expiration are displayed, allowing for continuous comparison of lung status over time.
The "Diagnostics" display facilitates practical analysis of ventilation distribution, regional compliance changes (CW, CL), and regional ventilation delays (RVD). This makes it an ideal tool for specific interventions, such as positive end-expiratory pressure (PEP) trials.
The use of the Dräger PressurePod, connected to the PulmoVista® 500, allows for the estimation of lung and chest wall elastance. By measuring transpulmonary pressure (Ptp) and esophageal pressure (Peso), clinicians can assess pulmonary mechanics, calculate spontaneous respiratory work, and determine the maximum level of strain on lung tissues.
In summary, the Dräger PulmoVista® 500 SW 1.30 redefines the standards of ventilatory and respiratory monitoring by providing unparalleled visibility into lung ventilation. Its intuitive and non-invasive use, combined with detailed parameter analysis, makes it an essential tool for clinicians seeking to optimize ventilation strategy and ensure high-quality respiratory care. The state-of-the-art electrical impedance tomography aligns with Dräger's ongoing commitment to innovation and improving healthcare.
